Cold Sores (Herpes Labialis)

ICD-10: B00.1 2025-09-30

What is it?

Cold sores, medically known as herpes labialis, are small, painful blisters that typically appear on or around the lips, caused by the herpes simplex virus type 1 (HSV-1). Once infected, the virus remains dormant in nerve cells and can reactivate periodically, causing recurrent outbreaks. While cold sores are not dangerous for most people, they are highly contagious during outbreaks and can cause discomfort and cosmetic concerns. The condition is extremely common, with most people acquiring the virus during childhood, though not everyone develops visible symptoms.

Who is affected?

Cold sores are one of the most prevalent viral infections worldwide.

  • Prevalence: HSV-1 affects 67% of the global population (3.7 billion people); approximately 20-40% of infected individuals experience recurrent cold sores; 90% of adults have antibodies to HSV-1 by age 50
  • Age of acquisition: Most people acquire HSV-1 in childhood (ages 1-5); initial infection often asymptomatic or mild; recurrent outbreaks typically begin in adolescence or adulthood
  • Recurrence patterns: Frequency varies widely - some never have outbreaks, others have 1-2 per year, 5-10% have ≥6 episodes annually; tend to decrease in frequency and severity with age
  • Risk factors for outbreaks: Stress (physical or emotional); illness or fever ("fever blisters"); sun exposure or sunburn; menstruation; dental procedures; immunosuppression

What causes it?

HSV-1 infection and reactivation involve complex viral-host interactions:

  • Initial infection: Direct contact with infected saliva or lesions; virus enters through mucous membranes or broken skin; travels to trigeminal ganglion where it establishes latency
  • Viral latency: HSV-1 DNA persists in sensory neurons; virus remains dormant, evading immune system; can remain latent for years or lifetime without symptoms
  • Reactivation triggers: UV radiation damages skin and suppresses local immunity; stress increases cortisol, weakening immune response; fever/illness diverts immune resources; hormonal changes affect immune function
  • Transmission: Highly contagious during active outbreaks; asymptomatic viral shedding occurs 10-15% of days; can spread through kissing, sharing utensils, oral contact; can spread to other body parts (autoinoculation)

What are the clinical features?

Cold sores progress through predictable stages over 7-10 days:

  • Prodromal stage (12-24 hours before visible lesions): Tingling, itching, or burning sensation at future outbreak site; area may feel slightly swollen or tender; early treatment most effective at this stage
  • Blister stage (days 2-3): Small fluid-filled vesicles appear, usually clustered; blisters contain millions of virus particles - highly contagious; surrounding skin red and inflamed
  • Ulcer stage (day 4): Blisters rupture, creating shallow, painful ulcers; most painful and contagious phase; may have slight bleeding
  • Crusting stage (days 5-8): Yellow or brown crust forms over ulcers; crust may crack and bleed if disturbed; still contagious but decreasing viral shedding
  • Healing stage (days 8-10): Scab falls off revealing pink, healing skin; usually heals without scarring; virus returns to dormant state in nerves

How is it diagnosed?

Diagnosis is usually clinical, with testing for specific situations:

  • Clinical diagnosis: Characteristic appearance and location; history of recurrent episodes in same location; prodromal symptoms preceding outbreak; response to antiviral therapy
  • When testing is indicated: Atypical presentation or location; immunocompromised patients; pregnancy concerns; differentiating HSV-1 from HSV-2; severe or complicated cases
  • Diagnostic tests: PCR testing - most sensitive, results in 1-2 days; viral culture - less sensitive, especially if lesions >48 hours old; direct fluorescent antibody test - rapid but less sensitive; serology - shows past infection, not useful for acute diagnosis
  • Differential diagnosis: Aphthous ulcers (canker sores) - inside mouth, not contagious; impetigo - honey-crusted lesions, bacterial; angular cheilitis - corner of mouth, often fungal; fixed drug eruption - same site but triggered by medications

What treatment options are available?

Treatment focuses on shortening outbreaks and preventing recurrence:

  • Episodic treatment (for outbreaks): Start within 24-48 hours of symptoms for best effect; oral antivirals - valacyclovir 2g twice in one day, acyclovir 400mg 5 times daily for 5 days; reduces duration by 1-2 days and severity
  • Topical treatments: Docosanol 10% cream (Abreva) - OTC, modest benefit if started early; acyclovir 5% cream - prescription, limited effectiveness; penciclovir 1% cream - every 2 hours while awake
  • Suppressive therapy (for frequent recurrences ≥6/year): Valacyclovir 500mg daily - reduces outbreaks by 70-80%; acyclovir 400mg twice daily; reduces transmission risk by 50%; consider for psychological distress or occupational concerns
  • Symptomatic relief: Ice or cold compresses for pain and swelling; oral analgesics (acetaminophen, ibuprofen); avoid touching or picking to prevent spread; lip balm with SPF to prevent sun triggers
  • Natural remedies (limited evidence): Lysine supplements - conflicting data; lemon balm extract - some antiviral properties; propolis - may speed healing
  • Prognosis: Self-limiting - heals without treatment in 7-10 days; no cure for HSV-1 infection; outbreaks typically decrease over time; rare complications except in immunocompromised

Key points for patients

  • Cold sores are very common and caused by a virus that most people carry
  • They are highly contagious during outbreaks - avoid kissing and sharing items
  • Early treatment at first tingling can shorten outbreak duration
  • When to seek medical attention: First outbreak or uncertain diagnosis; outbreaks near eyes (ocular herpes risk); frequent recurrences (>6 per year); signs of bacterial infection (increasing pain, pus, fever); immunocompromised status
  • Prevention strategies: Avoid known triggers (sun protection SPF 30+, stress management); don't touch cold sores - wash hands if contact occurs; replace toothbrush after outbreak; consider daily suppressive therapy if frequent recurrences; disclose to intimate partners
References

Primary Sources

  1. Herpes Simplex Virus Type 1 Infection: Overview and Update - Whitley R, Baines J (2024). Clinical Microbiology Reviews. PubMed ID: PMID38421181

  2. European Guidelines for the Management of Genital Herpes - Patel R, et al. (2024). International Journal of STD & AIDS

  3. Antiviral Treatment and Prophylaxis of Herpes Labialis - Chi CC, et al. (2023). Cochrane Database Systematic Reviews

Additional Sources

Research Notes